BeOne Medicines - Operating Income 2014-2025 | ONC

BeOne Medicines - annual/quarterly operating income history and growth rate from 2014 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

BeOne Medicines - operating income for the quarter ending September 30, 2025 was $0.163B, a 235.63% decline year-over-year.
BeOne Medicines - operating income for the twelve months ending September 30, 2025 was $0.183B, a 120.94% decline year-over-year.
BeOne Medicines - annual operating income for 2024 was $-0.568B, a 52.95% decline from 2023.
BeOne Medicines - annual operating income for 2023 was $-1.208B, a 32.52% decline from 2022.
BeOne Medicines - annual operating income for 2022 was $-1.79B, a 24.39% increase from 2021.

BeOne Medicines - Annual Operating Income (Millions of US $)
2024	$-568
2023	$-1,208
2022	$-1,790
2021	$-1,439
2020	$-1,658
2019	$-960
2018	$-706
2017	$-98
2016	$-117
2015	$-57
2014	$-16
2013	$-5

BeOne Medicines - Quarterly Operating Income (Millions of US $)
2025-09-30	$163
2025-06-30	$88
2025-03-31	$11
2024-12-31	$-79
2024-09-30	$-120
2024-06-30	$-107
2024-03-31	$-261
2023-12-31	$-384
2023-09-30	$-134
2023-06-30	$-319
2023-03-31	$-371
2022-12-31	$-469
2022-09-30	$-438
2022-06-30	$-439
2022-03-31	$-443
2021-12-31	$-572
2021-09-30	$-462
2021-06-30	$-475
2021-03-31	$70
2020-12-31	$-485
2020-09-30	$-440
2020-06-30	$-359
2020-03-31	$-374
2019-12-31	$-388
2019-09-30	$-312
2019-06-30	$-86
2019-03-31	$-174
2018-12-31	$-281
2018-09-30	$-151
2018-06-30	$-163
2018-03-31	$-111
2017-12-31	$-104
2017-09-30	$115
2017-06-30	$-58
2017-03-31	$-52
2016-12-31	$-37
2016-09-30	$-35
2016-06-30	$-25
2016-03-31	$-20
2015-12-31	$-26
2015-09-30
2015-06-30	$-7
2015-03-31	$-10
2014-12-31
2013-12-31

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$37.211B	$3.810B
BeOne Medicines is an oncology company which involved in discovering and developing treatments to cancer patients. BeOne Medicines, formerly known as BeiGene Ltd., is based in SAN CARLOS, Calif.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$91.260B	34.66
Zoetis (ZTS)	United States	$54.668B	19.57
Takeda Pharmaceutical (TAK)	Japan	$51.834B	10.58
Daiichi Sankyo, - (DSNKY)	Japan	$37.584B	18.72
Sandoz Group AG (SDZNY)	Switzerland	$35.741B	0.00
United Therapeutics (UTHR)	United States	$20.191B	17.77
Merck (MKKGY)	Germany	$19.464B	12.00
Shionogi (SGIOY)	Japan	$16.929B	15.55
IPSEN (IPSEY)	France	$13.608B	0.00
Neurocrine Biosciences (NBIX)	United States	$13.578B	32.58
Ionis Pharmaceuticals (IONS)	United States	$13.004B	0.00
Summit Therapeutics (SMMT)	United States	$12.716B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$10.912B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.411B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.967B	21.19
Stevanato Group S.p.A (STVN)	Italy	$5.230B	29.27
Crinetics Pharmaceuticals (CRNX)	United States	$5.046B	0.00
Corcept Therapeutics (CORT)	United States	$4.626B	49.98
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.547B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.209B	19.99
Indivior (INDV)	United States	$4.122B	16.82
NewAmsterdam Pharma (NAMS)	Netherlands	$3.778B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.397B	0.00
Hypermarcas (HYPMY)	Brazil	$2.977B	20.43
Catalyst Pharmaceuticals (CPRX)	United States	$2.898B	9.25
Dyne Therapeutics (DYN)	United States	$2.571B	0.00
Soleno Therapeutics (SLNO)	United States	$2.275B	0.00
Ocular Therapeutix (OCUL)	United States	$2.188B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.932B	37.21
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.916B	22.70
Ardelyx (ARDX)	United States	$1.888B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.731B	0.00
Oruka Therapeutics (ORKA)	United States	$1.665B	0.00
Harrow (HROW)	United States	$1.647B	101.07
Enliven Therapeutics (ELVN)	United States	$1.530B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.438B	7.12
BioCryst Pharmaceuticals (BCRX)	United States	$1.431B	84.88
Relay Therapeutics (RLAY)	United States	$1.288B	0.00
Evotec AG (EVO)	Germany	$1.282B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.234B	0.00
Savara (SVRA)	United States	$1.225B	0.00
Aktis Oncology (AKTS)	United States	$1.097B	0.00
Cronos Group (CRON)	Canada	$1.061B	0.00
Theravance Biopharma (TBPH)	United States	$1.026B	43.06
ARS Pharmaceuticals (SPRY)	United States	$1.009B	0.00
Xencor (XNCR)	United States	$0.913B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.851B	20.12
KalVista Pharmaceuticals (KALV)	United States	$0.810B	0.00
Nektar Therapeutics (NKTR)	United States	$0.755B	0.00
Esperion Therapeutics (ESPR)	United States	$0.751B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.671B	5.99
Bioventus (BVS)	United States	$0.664B	13.59
ProKidney (PROK)	United States	$0.653B	0.00
Altimmune (ALT)	United States	$0.574B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.547B	0.00
Lyell Immunopharma (LYEL)	United States	$0.537B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.505B	0.00
Organogenesis (ORGO)	United States	$0.498B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.488B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.487B	0.00
Siga Technologies (SIGA)	United States	$0.476B	6.51
4D Molecular Therapeutics (FDMT)	United States	$0.455B	0.00
Nature's Sunshine Products (NATR)	United States	$0.432B	25.70
USANA Health Sciences (USNA)	United States	$0.412B	11.49
Aquestive Therapeutics (AQST)	United States	$0.395B	0.00
Cybin (HELP)	Canada	$0.376B	0.00
Akebia Therapeutics (AKBA)	United States	$0.361B	0.00
Protara Therapeutics (TARA)	United States	$0.320B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.312B	0.00
Larimar Therapeutics (LRMR)	United States	$0.305B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.298B	0.00
Avalo Therapeutics (AVTX)	United States	$0.292B	0.00
Profound Medical (PROF)	Canada	$0.289B	0.00
Fractyl Health (GUTS)	United States	$0.286B	0.00
Relmada Therapeutics (RLMD)	United States	$0.286B	0.00
OmniAb (OABI)	United States	$0.282B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.268B	0.00
Heron Therapeutics (HRTX)	United States	$0.260B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.256B	0.00
Journey Medical (DERM)	United States	$0.236B	0.00
MediWound (MDWD)	Israel	$0.227B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.223B	0.00
Galectin Therapeutics (GALT)	United States	$0.213B	0.00
Century Therapeutics (IPSC)	United States	$0.212B	0.00
AleAnna (ANNA)	United States	$0.192B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Minerva Neurosciences (NERV)	United States	$0.172B	0.00
Surrozen (SRZN)	United States	$0.168B	0.00
Context Therapeutics (CNTX)	United States	$0.166B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
VAXART, INC (VXRT)	United States	$0.161B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.153B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.149B	0.00
Avita Medical (RCEL)	United States	$0.135B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.131B	0.00
Prelude Therapeutics (PRLD)	United States	$0.127B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.121B	0.00
Incannex Healthcare (IXHL)	Australia	$0.119B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.119B	0.00
Vivani Medical (VANI)	United States	$0.108B	0.00
Cassava Sciences (SAVA)	United States	$0.106B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.104B	0.00
Pyxis Oncology (PYXS)	United States	$0.101B	0.00
Korro Bio (KRRO)	United States	$0.101B	0.00
Champions Oncology (CSBR)	United States	$0.094B	39.71
Gain Therapeutics (GANX)	United States	$0.079B	0.00
PolyPid (PYPD)	Israel	$0.076B	0.00
Assertio Holdings (ASRT)	United States	$0.074B	0.00
Dominari Holdings (DOMH)	United States	$0.068B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.065B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.064B	0.00
Metagenomi Therapeutics (MGX)	United States	$0.063B	0.00
Rafael Holdings (RFL)	United States	$0.063B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.062B	0.00
Arch Biopartners (ACHFF)	Canada	$0.061B	0.00
Lipocine (LPCN)	United States	$0.061B	0.00
ElectroCore (ECOR)	United States	$0.060B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.059B	49.13
Nutriband (NTRB)	United States	$0.058B	0.00
Lite Strategy (LITS)	United States	$0.047B	0.00
Talphera (TLPH)	United States	$0.047B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Plus Therapeutics (PSTV)	United States	$0.038B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.038B	0.00
Wellgistics Health (WGRX)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.035B	0.00
SCYNEXIS (SCYX)	United States	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.031B	0.00
TherapeuticsMD (TXMD)	United States	$0.030B	0.00
Natural Alternatives (NAII)	United States	$0.026B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Scienture Holdings (SCNX)	United States	$0.021B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.019B	0.00
Traws Pharma (TRAW)	United States	$0.019B	0.02
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Inotiv (NOTV)	United States	$0.019B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vivos Therapeutics (VVOS)	United States	$0.017B	0.00
Tempest Therapeutics (TPST)	United States	$0.015B	0.00
Mannatech (MTEX)	United States	$0.015B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Nuvilex (PMCB)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Mangoceuticals (MGRX)	United States	$0.008B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.005B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00